Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Capelletti

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cancer Immunology Research|October 1, 2015
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung TumorsClaudia Voena, Matteo Menotti, Cristina Mastini, et al.
Cancer Cell|February 5, 2010
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLCAlexa B Turke, Kreshnik Zejnullahu, Yi-Long Wu, et al.
Cancer Research|October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogeneZhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.
Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Cell Reports|April 6, 2017
The Mutational Landscape of Circulating Tumor Cells in Multiple MyelomaYuji Mishima, Bruno Paiva, Jiantao Shi, et al.
Cancer Cell|December 10, 2014
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorCamilla L Christensen, Nicholas Kwiatkowski, Brian J Abraham, et al.
Nature Cancer|January 7, 2021
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaOksana Zavidij, Nicholas J Haradhvala, Tarek H Mouhieddine, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cancer Immunology Research|October 1, 2015
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung TumorsClaudia Voena, Matteo Menotti, Cristina Mastini, et al.
Cancer Cell|February 5, 2010
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLCAlexa B Turke, Kreshnik Zejnullahu, Yi-Long Wu, et al.
Cancer Research|October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogeneZhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.
Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2018
Amplification of Wild-type <i>KRAS</i> Imparts Resistance to Crizotinib in <i>MET</i> Exon 14 Mutant Non-Small Cell Lung CancerMagda Bahcall, Mark M Awad, Lynette M Sholl, et al.
Cell Reports|April 6, 2017
The Mutational Landscape of Circulating Tumor Cells in Multiple MyelomaYuji Mishima, Bruno Paiva, Jiantao Shi, et al.
Cancer Cell|December 10, 2014
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorCamilla L Christensen, Nicholas Kwiatkowski, Brian J Abraham, et al.
Nature Cancer|January 7, 2021
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaOksana Zavidij, Nicholas J Haradhvala, Tarek H Mouhieddine, et al.
Pageof 6